267 related articles for article (PubMed ID: 35628190)
1. Histone Modification on Parathyroid Tumors: A Review of Epigenetics.
Conti de Freitas LC; Castilho RM; Squarize CH
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628190
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.
Cardoso L; Stevenson M; Thakker RV
Hum Mutat; 2017 Dec; 38(12):1621-1648. PubMed ID: 28881068
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic alterations in human parathyroid tumors.
Verdelli C; Forno I; Vaira V; Corbetta S
Endocrine; 2015 Jun; 49(2):324-32. PubMed ID: 25722013
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid Tumors: Molecular Signatures.
Marini F; Giusti F; Iantomasi T; Brandi ML
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681865
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors.
Costa-Guda J; Arnold A
Mol Cell Endocrinol; 2014 Apr; 386(1-2):46-54. PubMed ID: 24035866
[TBL] [Abstract][Full Text] [Related]
6. Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism.
Farnebo F; Teh BT; Dotzenrath C; Wassif WS; Svensson A; White I; Betz R; Goretzki P; Sandelin K; Farnebo LO; Larsson C
Hum Genet; 1997 Mar; 99(3):342-9. PubMed ID: 9050920
[TBL] [Abstract][Full Text] [Related]
7. Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics.
Scarpelli D; D'Aloiso L; Arturi F; Scillitani A; Presta I; Bisceglia M; Cristofaro C; Russo D; Filetti S
J Endocrinol Invest; 2004 Dec; 27(11):1015-21. PubMed ID: 15754732
[TBL] [Abstract][Full Text] [Related]
8. Genetics of Hyperparathyroidism, Including Parathyroid Cancer.
Simonds WF
Endocrinol Metab Clin North Am; 2017 Jun; 46(2):405-418. PubMed ID: 28476229
[TBL] [Abstract][Full Text] [Related]
9. Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors.
Cetani F; Marcocci C; Torregrossa L; Pardi E
Endocr Relat Cancer; 2019 Jul; 26(7):R441-R464. PubMed ID: 31085770
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification.
Svedlund J; Koskinen Edblom S; Marquez VE; Åkerström G; Björklund P; Westin G
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1307-15. PubMed ID: 22544915
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathogenesis of parathyroid tumours.
Cinque L; Pugliese F; Salcuni AS; Scillitani A; Guarnieri V
Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):891-908. PubMed ID: 30477753
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathogenesis of primary hyperparathyroidism.
Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
[TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region.
Karges W; Jostarndt K; Maier S; Flemming A; Weitz M; Wissmann A; Feldmann B; Dralle H; Wagner P; Boehm BO
J Endocrinol; 2000 Jul; 166(1):1-9. PubMed ID: 10856877
[TBL] [Abstract][Full Text] [Related]
14. Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism.
Miedlich S; Krohn K; Lamesch P; Müller A; Paschke R
Eur J Endocrinol; 2000 Jul; 143(1):47-54. PubMed ID: 10870030
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetics and epigenetics of nonfamilial (sporadic) parathyroid tumours.
Westin G
J Intern Med; 2016 Dec; 280(6):551-558. PubMed ID: 27071708
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
Parfitt J; Harris M; Wright JM; Kalamchi S
J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological correlates of hyperparathyroidism.
Duan K; Gomez Hernandez K; Mete O
J Clin Pathol; 2015 Oct; 68(10):771-87. PubMed ID: 26163537
[TBL] [Abstract][Full Text] [Related]
18. The Oncosuppressors MEN1 and CDC73 Are Involved in lncRNA Deregulation in Human Parathyroid Tumors.
Morotti A; Forno I; Verdelli C; Guarnieri V; Cetani F; Terrasi A; Silipigni R; Guerneri S; Andrè V; Scillitani A; Vicentini L; Ferrero S; Corbetta S; Vaira V
J Bone Miner Res; 2020 Dec; 35(12):2423-2431. PubMed ID: 32780442
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism.
Carling T; Correa P; Hessman O; Hedberg J; Skogseid B; Lindberg D; Rastad J; Westin G; Akerström G
J Clin Endocrinol Metab; 1998 Aug; 83(8):2960-3. PubMed ID: 9709976
[TBL] [Abstract][Full Text] [Related]
20. Genomics and Epigenomics in Parathyroid Neoplasia: from Bench to Surgical Pathology Practice.
Juhlin CC; Erickson LA
Endocr Pathol; 2021 Mar; 32(1):17-34. PubMed ID: 33269427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
